Exploring the bioactivity of MicroRNAs Originated from Plant-derived Exosome-like Nanoparticles (PELNs): current perspectives

Abstract Exosomes, nano-sized extracellular vesicles, facilitate intercellular communication by transferring biomolecules such as microRNAs (miRNAs), which are key regulators of gene expression. While mammalian-derived exosomes (MDEs) have shown therapeutic promise, their clinical application has be...

Full description

Saved in:
Bibliographic Details
Main Authors: Kingsley Miyanda Tembo, Xiaohui Wang, Mansoor Bolideei, Qianrui Liu, Farouk Baboni, Mohammad Javad Mehran, Fei Sun, Cong-Yi Wang
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-025-03602-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849331666083905536
author Kingsley Miyanda Tembo
Xiaohui Wang
Mansoor Bolideei
Qianrui Liu
Farouk Baboni
Mohammad Javad Mehran
Fei Sun
Cong-Yi Wang
author_facet Kingsley Miyanda Tembo
Xiaohui Wang
Mansoor Bolideei
Qianrui Liu
Farouk Baboni
Mohammad Javad Mehran
Fei Sun
Cong-Yi Wang
author_sort Kingsley Miyanda Tembo
collection DOAJ
description Abstract Exosomes, nano-sized extracellular vesicles, facilitate intercellular communication by transferring biomolecules such as microRNAs (miRNAs), which are key regulators of gene expression. While mammalian-derived exosomes (MDEs) have shown therapeutic promise, their clinical application has been limited by challenges such as immune-related toxicities, low yield and high production costs. In contrast, plant-derived exosome-like nanoparticles (PELNs) offer a sustainable, biocompatible, and cost-effective alternative, encapsulating a diverse array of bioactive miRNAs with significant therapeutic potential. Studies have demonstrated the ability of PELN-derived miRNAs in cross-kingdom communication, effectively transferring into mammalian cells, where they modulate disease-related pathways, including cancer, inflammation, metabolism, and neurodegeneration. This review explores the bioactivity of plant-derived miRNAs, highlighting their role as novel therapeutic agents. The study explores the bioactivity and potential mechanisms by which these miRNAs influence human cellular processes, focusing on their ability to regulate gene expression in different tissues. Additionally, the study examines recent advances in PELN research, emphasizing their potential for clinical translation in precision medicine, and highlights challenges and future prospects in harnessing the therapeutic capabilities of these bioactive miRNAs. This review underscores the potential of PELNs to revolutionize therapeutic strategies, offering a sustainable, biocompatible, and cost-effective platform for targeted miRNA delivery, paving the way for innovative interventions leveraging nature’s own nanocarriers. Graphical Abstract
format Article
id doaj-art-0dd01e42b4d542e7a5d8fe9f09891dce
institution Kabale University
issn 1477-3155
language English
publishDate 2025-08-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj-art-0dd01e42b4d542e7a5d8fe9f09891dce2025-08-20T03:46:27ZengBMCJournal of Nanobiotechnology1477-31552025-08-0123114410.1186/s12951-025-03602-9Exploring the bioactivity of MicroRNAs Originated from Plant-derived Exosome-like Nanoparticles (PELNs): current perspectivesKingsley Miyanda Tembo0Xiaohui Wang1Mansoor Bolideei2Qianrui Liu3Farouk Baboni4Mohammad Javad Mehran5Fei Sun6Cong-Yi Wang7The Center for Biomedical Research, Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and TechnologyThe Center for Biomedical Research, Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and TechnologyThe Center for Biomedical Research, Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and TechnologyThe Center for Biomedical Research, Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and TechnologyInstitute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Department of Biotechnology, JSS Research Foundation, SJCE Technical Campus, University of MysoreThe Center for Biomedical Research, Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and TechnologyTongji Shanxi Hospital, Shanxi Bethune Hospital, Third Hospital of Shanxi Medical University, the Key Laboratory of Endocrine and Metabolic Diseases of Shanxi Province, Shanxi Medical UniversityAbstract Exosomes, nano-sized extracellular vesicles, facilitate intercellular communication by transferring biomolecules such as microRNAs (miRNAs), which are key regulators of gene expression. While mammalian-derived exosomes (MDEs) have shown therapeutic promise, their clinical application has been limited by challenges such as immune-related toxicities, low yield and high production costs. In contrast, plant-derived exosome-like nanoparticles (PELNs) offer a sustainable, biocompatible, and cost-effective alternative, encapsulating a diverse array of bioactive miRNAs with significant therapeutic potential. Studies have demonstrated the ability of PELN-derived miRNAs in cross-kingdom communication, effectively transferring into mammalian cells, where they modulate disease-related pathways, including cancer, inflammation, metabolism, and neurodegeneration. This review explores the bioactivity of plant-derived miRNAs, highlighting their role as novel therapeutic agents. The study explores the bioactivity and potential mechanisms by which these miRNAs influence human cellular processes, focusing on their ability to regulate gene expression in different tissues. Additionally, the study examines recent advances in PELN research, emphasizing their potential for clinical translation in precision medicine, and highlights challenges and future prospects in harnessing the therapeutic capabilities of these bioactive miRNAs. This review underscores the potential of PELNs to revolutionize therapeutic strategies, offering a sustainable, biocompatible, and cost-effective platform for targeted miRNA delivery, paving the way for innovative interventions leveraging nature’s own nanocarriers. Graphical Abstracthttps://doi.org/10.1186/s12951-025-03602-9MicroRNAs (miRNA)Plant-Derived Exosome-Like Nanoparticles (PELNs)Cross-Kingdom communicationBioactivityGene regulationTherapeutic potential
spellingShingle Kingsley Miyanda Tembo
Xiaohui Wang
Mansoor Bolideei
Qianrui Liu
Farouk Baboni
Mohammad Javad Mehran
Fei Sun
Cong-Yi Wang
Exploring the bioactivity of MicroRNAs Originated from Plant-derived Exosome-like Nanoparticles (PELNs): current perspectives
Journal of Nanobiotechnology
MicroRNAs (miRNA)
Plant-Derived Exosome-Like Nanoparticles (PELNs)
Cross-Kingdom communication
Bioactivity
Gene regulation
Therapeutic potential
title Exploring the bioactivity of MicroRNAs Originated from Plant-derived Exosome-like Nanoparticles (PELNs): current perspectives
title_full Exploring the bioactivity of MicroRNAs Originated from Plant-derived Exosome-like Nanoparticles (PELNs): current perspectives
title_fullStr Exploring the bioactivity of MicroRNAs Originated from Plant-derived Exosome-like Nanoparticles (PELNs): current perspectives
title_full_unstemmed Exploring the bioactivity of MicroRNAs Originated from Plant-derived Exosome-like Nanoparticles (PELNs): current perspectives
title_short Exploring the bioactivity of MicroRNAs Originated from Plant-derived Exosome-like Nanoparticles (PELNs): current perspectives
title_sort exploring the bioactivity of micrornas originated from plant derived exosome like nanoparticles pelns current perspectives
topic MicroRNAs (miRNA)
Plant-Derived Exosome-Like Nanoparticles (PELNs)
Cross-Kingdom communication
Bioactivity
Gene regulation
Therapeutic potential
url https://doi.org/10.1186/s12951-025-03602-9
work_keys_str_mv AT kingsleymiyandatembo exploringthebioactivityofmicrornasoriginatedfromplantderivedexosomelikenanoparticlespelnscurrentperspectives
AT xiaohuiwang exploringthebioactivityofmicrornasoriginatedfromplantderivedexosomelikenanoparticlespelnscurrentperspectives
AT mansoorbolideei exploringthebioactivityofmicrornasoriginatedfromplantderivedexosomelikenanoparticlespelnscurrentperspectives
AT qianruiliu exploringthebioactivityofmicrornasoriginatedfromplantderivedexosomelikenanoparticlespelnscurrentperspectives
AT faroukbaboni exploringthebioactivityofmicrornasoriginatedfromplantderivedexosomelikenanoparticlespelnscurrentperspectives
AT mohammadjavadmehran exploringthebioactivityofmicrornasoriginatedfromplantderivedexosomelikenanoparticlespelnscurrentperspectives
AT feisun exploringthebioactivityofmicrornasoriginatedfromplantderivedexosomelikenanoparticlespelnscurrentperspectives
AT congyiwang exploringthebioactivityofmicrornasoriginatedfromplantderivedexosomelikenanoparticlespelnscurrentperspectives